Catalyst Wire Dossier Catalyst Wire Dossier

CAIV-T

live attenuated influenza vaccine · MedImmune LLC
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for CAIV-T, covering 2006-10-03 to 2021-09-13. Get the full timeline:

Most recent: Clinical Trial Update: Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age [Phase 3]

See pricing